Mary Lancaster

Hogan Lovells

+ Follow Contact

Latest Publications

Share:

FDA Announces Qualified Health Claim for Consuming Oils with High Levels of Oleic Acid to Reduce Coronary Heart Disease Risk

The U.S. Food and Drug Administration (FDA) last month announced it would exercise enforcement discretion over two qualified health claims characterizing the relationship between the reduced risk of coronary heart disease...more

12/13/2018 / Class Action , Food and Drug Administration (FDA) , Food Supply , Health Claims , Regulatory Agenda , Regulatory Oversight

FDA Releases Plant and Animal Biotechnology Innovation Action Plan

The U.S. Food and Drug Administration (FDA) recently released its Plant and Animal Biotechnology Innovation Action Plan (“Action Plan”). The Action Plan provides an overview of the key priorities FDA expects to pursue through...more

11/27/2018 / Biotechnology , DNA , Food and Drug Administration (FDA) , Food Supply , Innovation , Plant Based Products , Public Health , Regulatory Agenda , Regulatory Oversight

USDA and FDA Announce Joint Oversight Over Cell Cultured Products

On Friday, November 16, 2018, the U.S. Department of Agriculture (USDA) Secretary Perdue and U.S. Food and Drug Administration (FDA) Commissioner Gottlieb announced a joint regulatory framework to oversee cell cultured...more

11/26/2018 / Food and Drug Administration (FDA) , Food Safety , Food Supply , Innovation , Regulatory Agenda , Regulatory Oversight , Regulatory Standards , USDA

53 Results

View per page

« Previous

Page: of 3